Viewing StudyNCT06118684



Ignite Creation Date: 2024-05-06 @ 7:44 PM
Last Modification Date: 2024-10-26 @ 3:13 PM
Study NCT ID: NCT06118684
Status: COMPLETED
Last Update Posted: 2024-02-28
First Post: 2023-10-20

Brief Title: Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin
Sponsor: EpiEndo Pharmaceuticals
Organization: EpiEndo Pharmaceuticals

Organization Data

Organization: EpiEndo Pharmaceuticals
Class: INDUSTRY
Study ID: EP395-004
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: EpiEndo Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
CTC Clinical Trial Consultants AB INDUSTRY